Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-09 |
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.2 | 6e-09 |
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-08 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-08 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-08 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |